Am J Physiol Gastrointest Liver Physiol 287: G115-G124, 2004.
First published March 4, 2004; doi:10.1152/ajpgi.00207.2003
0193-1857/04 $5.00
INFLAMMATION/IMMUNITY/MEDIATORS
Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling
Emile M. Rijcken ,1,*
Mike G. Laukoetter,1,*
Christoph Anthoni,1
Stephanie Meier,1
Rudolf Mennigen,1
Hans-Ullrich Spiegel,1
Matthias Bruewer,1
Norbert Senninger,1
Dietmar Vestweber,2 and
Christian F. Krieglstein1
1Department of General Surgery, Muenster University Hospital, Muenster; and 2Institute of Cell Biology, ZMBE, University of Muenster and Max-Planck-Institute of Vascular Biology, D-48149 Muenster, Germany
Submitted 6 May 2003
; accepted in final form 26 February 2004
Recruitment of circulating leukocytes into the colonic tissue is a key feature of intestinal inflammation. P-selectin glycoprotein ligand-1 (PSGL-1) and very late antigen-4 (VLA-4) are expressed on leukocytes and play an important role in leukocyte-endothelial cell adhesive interactions. We examined the effects of immunoneutralization of PSGL-1 and VLA-4 on leukocyte recruitment in vivo in the development and treatment of experimental colitis. Chronic colitis was induced in balb/c mice by oral administration of dextran sodium sulfate (DSS). Monoclonal antibodies 2PH1 (anti-PSGL-1) and PS/2 (anti-VLA-4) or the combination of both were injected intravenously, and leukocyte adhesion was observed for 60 min in colonic submucosal venules by intravital microscopy (IVM) under isoflurane/N2O anesthesia. In addition, mice with established colitis were treated by daily intraperitoneal injections of 2PH1, PS/2, or the combination of both over 5 days. Disease activity index (DAI), histology, and myeloperoxidase (MPO) levels were compared with sham-treated DSS controls. We found that 2PH1 reduced the number of rolling leukocytes (148.7 ± 29.8 vs. 36.9 ± 8.7/0.01 mm2/30 s, P < 0.05), whereas leukocyte velocity was increased (24.0 ± 3.6 vs. 127.8 ± 11.7 µm/s, P < 0.05). PS/2 reduced leukocyte rolling to a lesser extent. Leukocyte firm adhesion was not influenced by 2PH1 but was strongly reduced by PS/2 (24.1 ± 2 vs. 4.4 ± 0.9/0.01 mm2/30 s, P < 0.05). Combined application did not cause additional effects on leukocyte adhesion. Treatment of chronic colitis with 2PH1 or PS/2 reduced DAI, mucosal injury, and MPO levels significantly. Combined treatment led to a significantly better reduction of DAI (0.4 ± 0.1 vs. 2.1 ± 0.2 points) and histology (9.7 ± 0.9 vs. 21.4 ± 4.6 points). In conclusion, PSGL-1 and VLA-4 play an important role for leukocyte recruitment during intestinal inflammation. Therapeutic strategies designed to disrupt interactions mediated by PSGL-1 and/or VLA-4 may prove beneficial in treatment of chronic colitis.
P-selectin glycoprotein ligand-1; very late antigen-4; dextran sodium sulfate-colitis; selectins; inflammatory bowel disease
Address for reprint requests and other correspondence: C. F. Krieglstein, Dept. of General Surgery, Muenster Univ. Hospital, Waldeyerstr.1, D-48149 Muenster, Germany (E-mail: krieglstein{at}uni-muenster.de).
This article has been cited by other articles:

|
 |

|
 |
 
R. Mennigen, K. Nolte, E. Rijcken, M. Utech, B. Loeffler, N. Senninger, and M. Bruewer
Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis
Am J Physiol Gastrointest Liver Physiol,
May 1, 2009;
296(5):
G1140 - G1149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Schreiber, J. Petersson, M. Phillipson, M. Perry, S. Roos, and L. Holm
Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions
Am J Physiol Gastrointest Liver Physiol,
March 1, 2009;
296(3):
G534 - G542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Vowinkel, K. C. Wood, K. Y. Stokes, J. Russell, A. Tailor, C. Anthoni, N. Senninger, C. F. Krieglstein, and D. N. Granger
Mechanisms of platelet and leukocyte recruitment in experimental colitis
Am J Physiol Gastrointest Liver Physiol,
November 1, 2007;
293(5):
G1054 - G1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Rijcken, R. B. Mennigen, S. D. Schaefer, M. G. Laukoetter, C. Anthoni, H.-U. Spiegel, M. Bruewer, N. Senninger, and C. F. Krieglstein
PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis
Am J Physiol Gastrointest Liver Physiol,
August 1, 2007;
293(2):
G446 - G452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Anthoni, M. G. Laukoetter, E. Rijcken, T. Vowinkel, R. Mennigen, S. Muller, N. Senninger, J. Russell, J. Jauch, J. Bergmann, et al.
Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis
Am J Physiol Gastrointest Liver Physiol,
June 1, 2006;
290(6):
G1131 - G1137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mori, J. W. Salter, T. Vowinkel, C. F. Krieglstein, K. Y. Stokes, and D. N. Granger
Molecular determinants of the prothrombogenic phenotype assumed by inflamed colonic venules
Am J Physiol Gastrointest Liver Physiol,
May 1, 2005;
288(5):
G920 - G926.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Physiological Society.